SEC Filings

Filing date	Form	Description	View
06/05/14	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-14-009888.pdf 0001179110-14-009888.rtf 0001179110-14-009888.xls
06/05/14	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-14-009891.pdf 0001179110-14-009891.rtf 0001179110-14-009891.xls
06/05/14	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-14-009892.pdf 0001179110-14-009892.rtf 0001179110-14-009892.xls
06/05/14	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-14-009890.pdf 0001179110-14-009890.rtf 0001179110-14-009890.xls
06/05/14	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-14-009893.pdf 0001179110-14-009893.rtf 0001179110-14-009893.xls
06/05/14	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-14-009894.pdf 0001179110-14-009894.rtf 0001179110-14-009894.xls
06/04/14	4	Statement of changes in beneficial ownership of securities	View HTML 0000903423-14-000356.pdf 0000903423-14-000356.rtf 0000903423-14-000356.xls
06/03/14	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-14-043506.pdf 0001104659-14-043506.rtf 0001104659-14-043506.xls
05/19/14	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-14-008766.pdf 0001179110-14-008766.rtf 0001179110-14-008766.xls
05/15/14	CT ORDER	CT ORDER	View HTML 9999999997-14-009843.pdf

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools